Skip to main navigation
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • APVO436
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers
ADAPTIR immuno-oncology (I/O) biotech
Aptevo Therapeutics (NYSE:APVO)
Aptevo Therapeutics (NYSE:APVO)
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • Mipletamig
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers

Investors

Financial Information

  • SEC Filings
  • Annual Reports
  • Other Reports
  • Quarterly Results

SEC Filing Details

Document Details

Form
SCHEDULE 13G/A
Filing Date
02/17/26
Document Date
02/17/26
Form Description
SCHEDULE 13G/A - Description
Filing Group
Other
Company
Aptevo Therapeutics Inc
Issuer
Aptevo Therapeutics Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Quick Links

  • Stock Details
  • News
  • Events
  • Presentations
  • Financial Reports
  • Analyst Coverage
  • Spin-out Tax Documentation
  • Corporate Governance
  • Investor FAQ
  • Investor Contacts

Tools

  • Print
  • RSS Feeds
  • E-mail Alerts
  • Home
  • About Us
  • Our Technology
  • Pipeline
  • Investors
  • Careers
  • Contact Us
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Aptevo Terms and Conditions

© 2026 Aptevo Therapeutics